Press release
Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market to Reach USD 1.78 Billion by 2031 Amid Rising Outbreaks and Demand for Advanced Immunization Solutions
Request Sample @ https://clearviewmarketinsights.com/report-details/global-porcine-reproductive-respiratory-syndrome-prrs-vaccine-market/
2024 Industry Milestones:
Live Vaccine Efficacy Improvements
• Ingelvac PRRS MLV shows enhanced cross-protection in new trials.
• Ceva's thermostable PRRS vaccine gains approval in Southeast Asia.
Next-Gen Vaccine Platforms:
• MSD advances recombinant PRRS vaccine to Phase III in Europe.
• Prototype mRNA vaccine demonstrates 90% efficacy in U.S. swine trials.
Regional Expansion and Government Initiatives
• China launches Phase II of its National PRRS Control Program.
• Mexico introduces subsidies for PRRS vaccination in commercial farms.
Executive Insights:
PRRS remains the most economically devastating disease in swine. The urgency for broader, faster, and more effective immunization is driving historic innovation," said Dr. Emma Lawson, Head of Veterinary Research at Clearview Market Insights.
"We are witnessing the birth of the next era in veterinary immunology. PRRS vaccine innovation will set the tone for all future swine disease control efforts," added Antonio Velez, R&D Director, Ceva Animal Health.
Roadmap to 2031:
• 2025: PRRS vaccines included in national veterinary guidelines in 10 new countries.
• 2026: Intranasal PRRS vaccines account for 30% of Asia-Pacific use.
• 2028: First mRNA PRRS vaccine receives commercial approval in North America.
• 2030: Recombinant PRRS vaccines reach 40% market penetration.
• 2031: Integrated AI-vaccine protocols become standard in top 20 global producers.
For more insights, visit https://clearviewmarketinsights.com/
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
About Clearview Market Insights
Clearview Market Insights is a global leader in livestock and animal health research. Our experts track more than 100 animal vaccine markets worldwide, helping industry stakeholders make strategic, evidence-based decisions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Porcine Reproductive & Respiratory Syndrome (PRRS) Vaccine Market to Reach USD 1.78 Billion by 2031 Amid Rising Outbreaks and Demand for Advanced Immunization Solutions here
News-ID: 4020615 • Views: …
More Releases from ClearView Market Insights
Global Chromatography Syringe Market to Reach USD 1.96 Billion by 2031, Driven b …
[Chicago, 08 October 2025] - Clearview Market Insights (CVMI) predicts that the global chromatography syringe market will increase from USD 1.03 billion in 2024 to USD 1.96 billion by 2031, with a CAGR of 9.5%. The rising demand is due to growing pharmaceutical research, food safety testing, and environmental monitoring.
"Chromatography syringes are the backbone of precise analytical testing, ensuring accuracy and reliability in industries where quality matters most," said…
Global Chromatography Market to Exceed USD 30.2 Billion by 2031, Driven by Pharm …
[London, 06 October 2025] - Clearview Market Insights (CVMI) reports that the global chromatography market will grow from USD 14.85 billion in 2024 to USD 30.21 billion by 2031, at a CAGR of 10.4%. Increasing demand for analytical testing in pharmaceuticals, biotechnology, and environmental safety is driving market expansion.
"Chromatography has become an essential tool for ensuring product quality, safety, and compliance across various industries," said Dr. Rachel Bennett, senior…
Global Chordal Suture System Market to Surpass USD 1.06 Billion by 2031, Driven …
[Boston, 06 October 2025] - Clearview Market Insights (CVMI) projects that the global chordal suture system market will grow from USD 470 million in 2024 to USD 1.06 billion by 2031, registering a CAGR of 12.1%. This growth is driven by increasing adoption of minimally invasive mitral valve repair techniques and expanding treatment options for structural heart disease.
"Chordal suture systems are transforming the landscape of mitral valve repair by…
Global Chondroitin Sulfate Market to Exceed USD 3.4 Billion by 2031, Fueled by N …
[New York, 06 September 2025] - Clearview Market Insights (CVMI) predicts that the global chondroitin sulfate market will rise from USD 1.68 billion in 2024 to USD 3.41 billion by 2031, with a CAGR of 10.6%. Growing osteoarthritis cases, increased adoption of preventive healthcare, and expanding cosmetic uses drive the growth.
Request Sample: https://clearviewmarketinsights.com/report-details/global-chondroitin-sulfate-market/
"Chondroitin sulfate's versatility in pharmaceuticals, supplements, and cosmetics is positioning it as a high-demand bioactive ingredient worldwide,"…
More Releases for PRRS
Vaccine For Porcine Reproductive And Respiratory Syndrome (PRRS) Market Size by …
USA, New Jersey- According to Market Research Intellect, the global Vaccine For Porcine Reproductive And Respiratory Syndrome (PRRS) market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The Porcine Vaccine Due to the rising incidence of PRRS in swine populations worldwide, the market for reproductive…
PRRS Vaccines Market is expected to reach USD 2.53 billion by 2030: Cognitive Ma …
Market Overview:
Porcine Reproductive and Respiratory Syndrome, or PRRS, is a viral illness that affects people of all ages worldwide. PRRD is characterized by two symptoms such as reproductive dysfunction or failure in breeding animals and respiratory disease in pigs of any age. It is significant to highlight that, since the classic swine flu, PRRS has most significantly impacted the US economy through swine agriculture. PRRS symptoms include reproductive failure,…
PRRS Vaccines Market 2022: Expected Development, Share, Demand And Study Of Key …
The report released by MarketsandResearch.biz having the Global PRRS Vaccines Market. It includes high to bottom investigation of the connected essentials, and ex gratia information is completed to allow a transparent perspective on the business's business climate.
This can be accomplished through Porter's examination, SWOT investigation, and alternative explicit examination strategies. Our investigators have fastidiously audited the data to give the original precise premise to our future survey and guarantee acceptable…
Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market SWOT Ana …
Latest added Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market research study by HTF MI offers detailed product outlook and elaborates market review till 2025. The market Study is segmented by key regions that is accelerating the marketization. At present, the market is sharping its presence and some of the key players in the study are CNADC, Boehringer-Ingelheim, MSD Animal Health, Sinopharm, Ceva, Chengdu Tianbang Biological Products Co.,…
Global PRRS Vaccines Market| Research Report| Growth|Market Research and Forecas …
Global PRRS Vaccines Market Overview:
The latest report on the Global PRRS Vaccines Market suggests a positive growth rate in the coming years. Analysts have studied the historical data and compared it with the current market scenario to determine the trajectory this market will take in the coming years. The investigative approach taken to understand the various aspects of the market is aimed at giving the readers a holistic view…
Industry Data Analysis - Global PRRS Vaccines Sales Market Report 2019-2015
A PRRS Vaccines designed to protect the wearer's face and eyes and prevent the breathing of air contaminated with chemical and/or biological agents.
In this report, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for PRRS Vaccines.
This report studies the global market size of PRRS Vaccines, especially focuses on the key regions like United States, European Union, China, and…
